Algenex
Pozuelo De Alarc├│n · Founded 2005
About Algenex
Algenex is a developer of vector-based innovative technologies designed to manufacture recombinant proteins. The company's technologies use a baculovirus expression vector system for vaccine manufacturing, diagnostic reagents, crystallography, HTS and therapeutic molecules.
Company Facts
- Founded: 2005
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.5M
- Last round: Series Unknown (Mar 2019)
- Website: algenex.com
- Phone: +34 914 524 941
Industries & Categories
Biotechnology, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/algenex-74534 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.